BioMarin Pharmaceutical (NASDAQ:BMRN)

Citigroup Sees Big Upside for 2 of the Largest Biotechs

Posted: May 23, 2019 at 11:40 am

After quite some time of muted or negative performance, big biotech may be worth a look again. Citigroup analyst Mohit Bansal assumed coverage of the large-cap biotech space and sees ...
Read Full Story »

5 Goldman Sachs Conviction List Stocks Have Gigantic Implied Upside

Posted: March 20, 2019 at 7:20 am

With 2019 well underway, and the first quarter almost over, many investors are resetting for what could be a more volatile rest of the year as the ongoing trade issues ...
Read Full Story »

5 Stocks on Goldman Sachs Conviction List With Massive Upside Potential

Posted: February 6, 2019 at 7:05 am

With 2019 off and running and the first quarter now almost half over, many investors are resetting for what could be a more volatile remainder of the year as the ...
Read Full Story »

Why 6 Top Biotech Stocks Could Beat Wall Street Q4 Estimates

Posted: January 31, 2019 at 7:40 am

If most investors thought their portfolios took a beating during the final quarter of 2018, it was a good thing they were not all-in on the biotechnology segment. The VanEck ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More

Posted: January 2, 2019 at 9:15 am

Stocks entered the new year on a sour note, with equity futures down about 1.5% after weaker Chinese economic data. While investors used to buy every sell-off, the volatility in ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

Posted: December 14, 2018 at 9:14 am

The futures traded down triple digits Friday morning as investors digested a very volatile trading week. Continued positive talk on trade, with China acknowledging the resumption of soybean and oil ...
Read Full Story »

Top Biotech Earnings Reports to Watch This Week

Posted: October 21, 2018 at 10:15 am

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week. While ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Athenahealth, Illumina, Northrop Grumman, Square, Twitter, Yamana Gold and More

Posted: July 31, 2018 at 8:55 am

Stocks were indicated to open marginally higher on Tuesday morning after a larger sell-off on Monday. Investors have been having less success buying the stock market dips in 2018 than in ...
Read Full Story »

Biopharma Companies to Watch This Week

Posted: June 24, 2018 at 10:15 am

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Biopharma Companies to Watch This Week and for the Rest of June

Posted: June 9, 2018 at 9:25 am

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Starbucks, Splunk, PayPal, L Brands, Medtronic, Gap, Novartis and More

Posted: May 25, 2018 at 9:10 am

The broad markets were looking soft ahead of the open on Friday, although hopefully not too soft as the Dow Jones industrial average and S&P 500 are looking to close ...
Read Full Story »

The Top Biopharma Catalysts Coming in May

Posted: May 5, 2018 at 8:40 am

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

Posted: April 22, 2018 at 10:15 am

The health care sector has yet to see any significant earnings representation, but that will change this week. In fact, pharmaceutical and biotech investors are about to get a real earnings ...
Read Full Story »

4 Red-Hot Biotech Stocks to Buy Before Earnings

Posted: April 18, 2018 at 8:20 am

If there is any industry that can blow hot and then very cold on Wall Street, it’s biotechnology, and with good reason. Like big pharmaceuticals, politicians love to target biotechs ...
Read Full Story »

Why 4 Top Biotech Stocks May Be the Next Takeover Targets

Posted: April 16, 2018 at 8:15 am

Last week, Novartis A.G. (NYSE: NVS) announced a huge $8.7 billion all-cash purchase of AveXis Inc.(NASDAQ: AVXS), and many on Wall Street think there is a good chance that mergers ...
Read Full Story »